461 related articles for article (PubMed ID: 29991134)
21. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
[TBL] [Abstract][Full Text] [Related]
22. Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
Hong H; Li Y; Su B
J Alzheimers Dis; 2017; 59(4):1449-1458. PubMed ID: 28731435
[TBL] [Abstract][Full Text] [Related]
23. Circadian and sleep phenotypes in a mouse model of Alzheimer's disease characterized by intracellular accumulation of amyloid β oligomers.
Sato T; Ochiishi T; Higo-Yamamoto S; Oishi K
Exp Anim; 2024 May; 73(2):186-192. PubMed ID: 38092387
[TBL] [Abstract][Full Text] [Related]
24. Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease.
Born HA; Kim JY; Savjani RR; Das P; Dabaghian YA; Guo Q; Yoo JW; Schuler DR; Cirrito JR; Zheng H; Golde TE; Noebels JL; Jankowsky JL
J Neurosci; 2014 Mar; 34(11):3826-40. PubMed ID: 24623762
[TBL] [Abstract][Full Text] [Related]
25. Interictal spikes during sleep are an early defect in the Tg2576 mouse model of β-amyloid neuropathology.
Kam K; Duffy ÁM; Moretto J; LaFrancois JJ; Scharfman HE
Sci Rep; 2016 Jan; 6():20119. PubMed ID: 26818394
[TBL] [Abstract][Full Text] [Related]
26. Alteration in sleep architecture and electroencephalogram as an early sign of Alzheimer's disease preceding the disease pathology and cognitive decline.
Zhang F; Zhong R; Li S; Fu Z; Wang R; Wang T; Huang Z; Le W
Alzheimers Dement; 2019 Apr; 15(4):590-597. PubMed ID: 30819626
[TBL] [Abstract][Full Text] [Related]
27. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
[TBL] [Abstract][Full Text] [Related]
28. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
29. Sleep architecture changes in the APP23 mouse model manifest at onset of cognitive deficits.
Van Erum J; Van Dam D; Sheorajpanday R; De Deyn PP
Behav Brain Res; 2019 Nov; 373():112089. PubMed ID: 31325518
[TBL] [Abstract][Full Text] [Related]
30. Genetic deletion of CB
Aso E; Andrés-Benito P; Ferrer I
Biochem Pharmacol; 2018 Nov; 157():210-216. PubMed ID: 30096288
[TBL] [Abstract][Full Text] [Related]
31. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
32. Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) mice.
Knight EM; Brown TM; Gümüsgöz S; Smith JC; Waters EJ; Allan SM; Lawrence CB
Dis Model Mech; 2013 Jan; 6(1):160-70. PubMed ID: 22864021
[TBL] [Abstract][Full Text] [Related]
33. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease.
Duncan MJ; Smith JT; Franklin KM; Beckett TL; Murphy MP; St Clair DK; Donohue KD; Striz M; O'Hara BF
Exp Neurol; 2012 Aug; 236(2):249-58. PubMed ID: 22634208
[TBL] [Abstract][Full Text] [Related]
34. The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease.
Zheng H; Zhou Q; Du Y; Li C; Xu P; Lin L; Xiao J; Gao H
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):263-273. PubMed ID: 29107091
[TBL] [Abstract][Full Text] [Related]
35. APP/PS1 transgenic mice treated with aluminum: an update of Alzheimer's disease model.
Zhang QL; Jia L; Jiao X; Guo WL; Ji JW; Yang HL; Niu Q
Int J Immunopathol Pharmacol; 2012; 25(1):49-58. PubMed ID: 22507317
[TBL] [Abstract][Full Text] [Related]
36. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
[TBL] [Abstract][Full Text] [Related]
37. High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease.
Taheri S; Yu J; Zhu H; Kindy MS
J Alzheimers Dis; 2016 Oct; 54(3):1061-1072. PubMed ID: 27567835
[TBL] [Abstract][Full Text] [Related]
38. Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.
Shen L; Liu L; Ji HF
J Alzheimers Dis; 2017; 56(1):385-390. PubMed ID: 27911317
[TBL] [Abstract][Full Text] [Related]
39. Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1ΔE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease.
Thygesen C; Metaxas A; Larsen MR; Finsen B
J Alzheimers Dis; 2018; 64(4):1247-1259. PubMed ID: 29991132
[TBL] [Abstract][Full Text] [Related]
40. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
